Affiliation:
1. Chuvash State University named after I.N. Ulyanov
2. K.G. Razumovsky Moscow State University of Technologies and Management (the First Cossack University)
3. Research Institute of Health Organization and Medical Management of Moscow Healthcare Department
4. State University of Management
Abstract
The purpose of the work is to study the features of the body mass index (BMI) in schizophrenia patients (SP) who live in Chuvashia. Material and methods. 607 SP were examined (307 men and 300 women) aged 18 to 82 (average - 44.51 ± 12.3 years). The diagnosis of schizophrenia met the criteria for ICD-10 (F20-29); disease duration ranged from 0 to 52 years (mean - 18.9 ± 10.7 years). BMI was taken into account according to the Ketle index. For each SP, a survey card with clinical, therapeutic, and socio-demographic indices was filled out. The comparison group included a sample of 3417 residents of Chuvashia. Mathematical and statistical processing was carried out using descriptive statistics and χ2 distribution. Results. 9.2% of SP had underweight, 54.2% - normal body weight, 36.6% - excess body weight and obesity. Among women there were significantly more persons with increased BMI and obesity, among men - with normal BMI. In SP, BMI did not depend on the group of taken antipsychotics (typical, atypical, mixed-use) and the disease’s duration. With patients’ age, BMI increased to excess BMI (25-29.9 kg/m2). Among SP, persons with underweight were much more common (among healthy people, 2% vs 9.2% in SP). From 40 years of age and older, among the healthy population, persons with an increased BMI and obesity begin to predominate significantly compared with the SP group. Observations of BMI during inpatient treatment from 1.5 to 22 months showed multidirectional dynamics, including increased body weight in 42.2% of SP, a decrease in 30.1%, without changes in BMI in 27.7%; it was not possible to retrospectively identify any patterns of BMI fluctuations. Conclusion. The revealed paradoxes of BMI for SP in Chuvashia, especially a high proportion of SP with underweight, require refinement considering ethnic, genetic, sex and age, hormon and metabolic factors.
Publisher
Federal Scientific Center for Hygiene F.F.Erisman
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference30 articles.
1. NCD Risk Factor Collaboration (NCD-RisC) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016; 387(10026): 1377–96. https://doi.org/10.1016/S0140-6736(16)30054-X
2. Tek Ts., Kutsukgontsu S., Guloksuz S., Vuds S.V., Srikhari V.Kh., Annamalay A. Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications. Sotsial’naya i klinicheskaya psikhiatriya, 2016; 26(1): 45–9. (in Russian)
3. Chiliza B., Asmal L., Oosthuizen P., van Niekerk E., Erasmus R., Kidd M., et al. Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic. Eur. Psychiatry. 2015; 30(2): 277–83. https://doi.org/10.1016/j.eurpsy.2014.11.013
4. Gu X.J., Chen R., Sun C.H., Zheng W., Yang X.H., Wang S.B., et al. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials. J. Int. Med. Res. 2017; 46(1): 22–32. https://doi.org/10.1177/0300060517716783
5. Sugai T., Suzuki Y., Yamazaki M., Shimoda K., Mori T., Ozeki Y., et al. High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey. BMJ Open. 2015; 5(12): e008720. https://doi.org/10.1136/bmjopen-2015-008720
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献